The use of a glucose-reduced graphene oxide suspension for photothermal cancer therapy

2012 ◽  
Vol 22 (27) ◽  
pp. 13773 ◽  
Author(s):  
Omid Akhavan ◽  
Elham Ghaderi ◽  
Samira Aghayee ◽  
Yasamin Fereydooni ◽  
Ali Talebi
Keyword(s):  
Graphene Oxide ◽  
Cancer Therapy ◽  
Reduced Graphene Oxide ◽  
Reduced Graphene

scholarly journals Synthesis of novel cyclodextrin-modified reduced graphene oxide composites by a simple hydrothermal method

RSC Advances ◽  
2018 ◽  
Vol 8 (66) ◽  
pp. 37623-37630 ◽  
Author(s):  
Qingli Huang ◽  
MingYan Li ◽  
LiLi Wang ◽  
Honghua Yuan ◽  
Meng Wang ◽  
...  
Keyword(s):  
Graphene Oxide ◽  
Cancer Therapy ◽  
Drug Release ◽  
Hydrothermal Method ◽  
Reduced Graphene Oxide ◽  
Sustained Drug Release ◽  
Simple Hydrothermal Method ◽  
Ph Response ◽  
Reduced Graphene ◽  
Oxide Composites

The rGO@CD@PEG@FA nanocomposite showed the stimulative effect of heat, pH response, and sustained drug release for cancer therapy

Chrysin-Anchored Silver and Gold Nanoparticle-Reduced Graphene Oxide Composites for Breast Cancer Therapy

2020 ◽  
Vol 3 (5) ◽  
pp. 4574-4585 ◽  
Author(s):  
Sathishkumar Gnanasekar ◽  
Dhivyabharathi Balakrishnan ◽  
Prabukumar Seetharaman ◽  
Pugazhendhi Arivalagan ◽  
Rajkuberan Chandrasekaran ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Graphene Oxide ◽  
Cancer Therapy ◽  
Gold Nanoparticle ◽  
Reduced Graphene Oxide ◽  
Breast Cancer Therapy ◽  
Reduced Graphene ◽  
Oxide Composites

scholarly journals Plasmonic photothermal cancer therapy with gold nanorods/reduced graphene oxide core/shell nanocomposites

RSC Advances ◽  
2016 ◽  
Vol 6 (2) ◽  
pp. 1600-1610 ◽  
Author(s):  
Kostiantyn Turcheniuk ◽  
Tetiana Dumych ◽  
Rostyslav Bilyy ◽  
Volodymyr Turcheniuk ◽  
Julie Bouckaert ◽  
...  
Keyword(s):  
Graphene Oxide ◽  
Cancer Therapy ◽  
Reduced Graphene Oxide ◽  
Photon Energy ◽  
Gold Nanorods ◽  
Core Shell ◽  
Efficient Conversion ◽  
Reduced Graphene

Gold nanorods (Au NRs) are known for their efficient conversion of photon energy into heat, resulting in hyperthermia and suppression of tumor growths in vitro and in vivo.

Synthesis of biologically-active reduced graphene oxide by using fucoidan as a multifunctional agent for combination cancer therapy

2018 ◽  
Vol 29 (47) ◽  
pp. 475604 ◽  
Author(s):  
Seounghun Kang ◽  
Yu Lim Hong ◽  
Bon-Cheol Ku ◽  
Seunghyun Lee ◽  
Seongwoo Ryu ◽  
...  
Keyword(s):  
Graphene Oxide ◽  
Cancer Therapy ◽  
Reduced Graphene Oxide ◽  
Biologically Active ◽  
Reduced Graphene ◽  
Combination Cancer Therapy

scholarly journals Iron Hydroxide/Oxide-Reduced Graphene Oxide Nanocomposite for Dual-Modality Photodynamic and Photothermal Therapy In Vitro and In Vivo

Nanomaterials ◽  
2021 ◽  
Vol 11 (8) ◽  
pp. 1947
Author(s):  
Wei-Jane Chiu ◽  
Yi-Chun Chen ◽  
Chih-Ching Huang ◽  
Lingyan Yang ◽  
Jiantao Yu ◽  
...  
Keyword(s):  
Graphene Oxide ◽  
Cancer Therapy ◽  
Reduced Graphene Oxide ◽  
Near Infrared ◽  
High Efficiency ◽  
Iron Hydroxide ◽  
Ros Generation ◽  
Irreversible Damage ◽  
Reduced Graphene

Minimal invasive phototherapy utilising near-infrared (NIR) laser to generate local reactive oxygen species (ROS) and heat has few associated side effects and is a precise treatment in cancer therapy. However, high-efficiency and safe phototherapeutic tumour agents still need developing. The application of iron hydroxide/oxide immobilised on reduced graphene oxide (FeOxH–rGO) nanocomposites as a therapeutic agent in integration photodynamic cancer therapy (PDT) and photothermal cancer therapy (PTT) was discussed. Under 808 nm NIR irradiation, FeOxH–rGO offers a high ROS generation and light-to-heat conversion efficiency because of its strong NIR absorption. These phototherapeutic effects lead to irreversible damage in FeOxH–rGO-treated T47D cells. Using a tumour-bearing mouse model, NIR ablated the breast tumour effectively in the presence of FeOxH–rGO. The tumour treatment response was evaluated to be 100%. We integrated PDT and PTT into a single nanodevice to facilitate effective cancer therapy. Our FeOxH–rGO, which integrates the merits of FeOxH and rGO, displays an outstanding tumoricidal capacity, suggesting the utilization of this nanocomposites in future medical applications.

Tumor targeting dual stimuli responsive controllable release nanoplatform based on DNA-conjugated reduced graphene oxide for chemo-photothermal synergetic cancer therapy

2018 ◽  
Vol 6 (26) ◽  
pp. 4360-4367 ◽  
Author(s):  
Wenjing Jiang ◽  
Fan Mo ◽  
Yaohui Lin ◽  
Xusheng Wang ◽  
LiangJun Xu ◽  
...  
Keyword(s):  
Drug Delivery ◽  
Graphene Oxide ◽  
Cancer Therapy ◽  
Reduced Graphene Oxide ◽  
Tumor Targeting ◽  
Stimuli Responsive ◽  
Release Drug ◽  
Reduced Graphene ◽  
Controllable Release

A tumor targeting dual stimuli responsive controllable release drug delivery nanoplatform was fabricated for chemo-photothermal synergetic cancer therapy based on DNA-conjugated reduced graphene oxide.

Sign in / Sign up

Export Citation Format

Share Document